NewAmsterdam

NAP is a Netherland-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cardio-metabolic diseases.

Business Model:

Revenue: $0

Employees: 11-50

Detailed NewAmsterdam Information

Geographic Data

NewAmsterdam headquarters map

Address: Gooimeer 2-35

City: Naarden

State: noord-holland

Zip: 1411

Country: NL

Financial Info

Stage:

series a

Raised Last:

$194M

Raised Total:

$194M

Metrics

6,823,254Website Global Rank

697Website Monthly Traffic

Twitter Followers

Description

NAP is a Netherland-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cardio-metabolic diseases.

Contact Phone:

Contact Email:

NewAmsterdam went public on the NASDAQ

Listed Exchange:
NASDAQ

Ticker Symbol:
NAMS

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
11/2022 Post-IPO Equity $0 RA Capital Management
Panacea Venture
Morningside Ventures
Medicxi
LSP Dementia Fund
GMT Capital
Frazier Healthcare Partners
Forbion Capital Partners
Bain Capital Life Sciences
RA Capital Management
Panacea Venture
Morningside Ventures
Medicxi
LSP Dementia Fund
GMT Capital
Frazier Healthcare Partners
Forbion Capital Partners
Bain Capital Life Sciences
1/2019 Venture Round 1 - BioGeneration Ventures
BioGeneration Ventures
1/2021 Series A $196M Morningside Ventures
Kaiser Foundation Hospitals
BVF Partners L.P
Population Health Partners
LSP Dementia Fund
Janus Henderson Investors
Medpace
GL Capital
JVC Investment Partners
Presight Capital
Forbion Capital Partners
11/2022 IPO SPAC -
1/2021 Series A $0 Ascendant BioCapital
BVF Partners
Forbion Capital Partners
GL Capital
Janus Henderson Investors
JVC Investment Partners
Kaiser Foundation Hospitals
LSP BioVentures
Medpace
Morningside Venture Investments
Peter Thiel
Population Health Partners
Presight Capital
Ascendant BioCapital
BVF Partners
Forbion Capital Partners
GL Capital
Janus Henderson Investors
JVC Investment Partners
Kaiser Foundation Hospitals
LSP BioVentures
Medpace
Morningside Venture Investments
Peter Thiel
Population Health Partners
Presight Capital
11/2022 IPO SPAC -

1/2021 Series A 13 $194.4M Ascendant BioCapital
BVF Partners
Forbion Capital Partners
GL Capital
Janus Henderson Investors
JVC Investment Partners
Kaiser Foundation Hospitals
LSP BioVentures
Medpace
Morningside Venture Investments
Peter Thiel
Population Health Partners
Presight Capital
Ascendant BioCapital
BVF Partners
Forbion Capital Partners
GL Capital
Janus Henderson Investors
JVC Investment Partners
Kaiser Foundation Hospitals
LSP BioVentures
Medpace
Morningside Venture Investments
Peter Thiel
Population Health Partners
Presight Capital
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research